Intensity Therapeutics, Inc. INTS 深 滬
等待開盤 05-22 09:30:00 美东时间
4.71
+0.080
+1.73%
華盛通- 最 高4.72
- 今 開4.69
- 成交量 1.17万股
- 最 低 4.5901
- 昨 收 4.63
- 總市值 1273.03万
- 52周最高 43.50
- 市盈率 靜 --
- 換手率 0.43%
- 52周最低 4.50
- 委 比 69.38%
- 總股本 270.28万
- 歷史最高 286.00
- 量 比 0.53
- 振 幅 2.81%
- 歷史最低 4.5901
- 每 手 1
- 風險率 2.83%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Intensity Therapeutics Recognized with GHP Magazine's 2026 Healthcare & Pharmaceutical Award
Company receives the Cancer Treatment Technology Innovator of the Year award SHELTON, Conn., May 14, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc., (Nasdaq: INTS) ("Intensity" or the "Co...
05-14 20:00
Intensity Therapeutics Q1 EPS $(0.96) Beats $(1.11) Estimate
Intensity Therapeutics (NASDAQ:INTS) reported quarterly losses of $(0.96) per share which beat the analyst consensus estimate of $(1.11) by 13.51 percent. This is a 82.55 percent increase over losses of $(5.50) per share
05-08 04:50
Intensity Therapeutics Q1 EPS $(0.96) Beats $(1.11) Estimate
Unity Software(U.US) reported fourth-quarter financial results after the market...
05-08 04:50
快讯 | Intensity Therapeutics 第一季度营业总收入（单位：美元）-252.6万
Intensity Therapeutics Q1 Operating Income USD -2.526 Million
05-08 04:06
快讯 | Intensity Therapeutics 报告了2026年第一季度的财务业绩并提供了公司更新。
Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provide...
05-08 04:06
Intensity Therapeutics Q4 EPS $(1.31) Misses $(0.04) Estimate
Intensity Therapeutics (NASDAQ:INTS) reported quarterly losses of $(1.31) per share which missed the analyst consensus estimate of $(0.04) by 2946.51 percent. This is a 76.18 percent increase over losses of $(5.50) per
03-28 04:18
Intensity Therapeutics Issued New U.S. Patent Entitled 'A Method of Treating Cancer'
Intensity Therapeutics, Inc., (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the discovery and development of proprietary cancer therapies using its non-covalent,
03-24 20:09
Intensity Therapeutics Expands ATM Offering Capacity To $60M; May Issue Up To $60M Of Common Stock Under Offering Agreement
Other EventsOn March 23, 2026, Intensity Therapeutics, Inc. (the "Company") filed a prospectus supplement to increase the capacity of its existing "at-the-market" offering program (the "ATM") to $60.0 million. While this
03-24 04:03
BUZZ-U.S. STOCKS ON THE MOVE-SciSparc, Natera, US energy companies
BUZZ-U.S. STOCKS ON THE MOVE-SciSparc, Natera, US energy companies Workspace search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 March 12 (Reuters) - Wall Street's main indexes were set to ope
03-12 21:20
BUZZ-Intensity Therapeutics rises as breast cancer drug shows early promise
BUZZ-Intensity Therapeutics rises as breast cancer drug shows early promise ** Shares of biotech firm Intensity Therapeutics INTS.O rise about 3.5% to $8.19 premarket ** Co says its experimental drug, INT230-6, showed encouraging early results in a small study in triple-negative breast cancer - an a
03-12 19:40
